News Select Year All Years 2025 (35) 2024 (31) 2023 (31) 2022 (35) 2021 (28) 2020 (36) 2019 (46) 2018 (51) 2017 (34) 2016 (26) 2015 (42) 2014 (30) 2013 (26) 2012 (23) 2011 (28) 2010 (36) 2009 (39) 2008 (55) 2007 (50) Clinical Trials Select Clinical Trial AWARE-1 (20) BRACELET-1 (10) GOBLET (32) Search … June 20, 2012 Oncolytics Announces Independent Data Monitoring Committee Recommends Continued Enrollment in Phase III Study of REOLYSIN® in Head and Neck Cancers Following Review of Safety Data June 18, 2012 Media Advisory – Oncolytics Biotech® Inc. to Present at Bloom Burton & Co. Healthcare Investor Conference June 15, 2012 Oncolytics Biotech® Inc. Announces Details of 2012 Annual and Special Meeting of Shareholders June 13, 2012 Oncolytics Biotech® Inc. Announces Publication of Translational Clinical Trial Results in Science Translational Medicine June 5, 2012 Oncolytics Biotech® Inc. Enters into Sponsorship Agreement with NCIC CTG for Randomized Phase II Study in Non-Small Cell Lung Cancer May 15, 2012 Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch 2012 Heath Care Conference May 10, 2012 Oncolytics Biotech® Inc. Announces First Quarter 2012 Results May 3, 2012 Oncolytics Biotech® Inc. Enters into Sponsorship Agreement with NCIC CTG for Randomized Phase II Study in Colorectal Cancer April 4, 2012 Media Advisory – Oncolytics Biotech® Inc. to Present at 11th Annual Needham Healthcare Conference April 2, 2012 Oncolytics Biotech® Inc. Completes Enrollment in First Stage of Phase III Study in Head and Neck Cancers Newer Page 47 of 69 Older